Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma

Marcelo A. Navarrete, Kristina Heining-Mikesch, Frank Schüler, Cristina Bertinetti-Lapatki, Gabriele Ihorst, Andrea Keppler-Hafkemeyer, Gottfried Dölken, Hendrik Veelken

Blood (2011) 117 (5): 1483–1491.

https://doi.org/10.1182/blood-2010-06-292342

Published: 2011

Includes: Supplemental data

Journal Articles

HLA-Dependent Immune Selection Pressure on the Idiotype Is Predominantly Driven by Somatic Hypermutation In Malignant Lymphoma but Also Modulates Vh Usage In Normal B Cells

Dimitrios Papaioannou, M.D., Anna-Maria Strothmeyer, M.D., Marcus Dühren-von Minden, M.Sc., Marcelo A. Navarrete, M.D., Katja Zirlik, MD, Kristina Heining-Mikesch, M.D., Hendrik Veelken, M.D., Ph.D.

Blood (2010) 116 (21): 3132.

https://doi.org/10.1182/blood.V116.21.3132.3132

Published: 2010

Journal Articles

Comparative analysis of predicted HLA binding of immunoglobulin idiotype sequences indicates T cell–mediated immunosurveillance in follicular lymphoma

Anna-Maria Strothmeyer, Dimitrios Papaioannou, Marcus Dühren-von Minden, Marcelo Navarrete, Katja Zirlik, Kristina Heining-Mikesch, Hendrik Veelken

Blood (2010) 116 (10): 1734–1736.

https://doi.org/10.1182/blood-2010-02-270199

Published: 2010

Includes: Supplemental data

Journal Articles

Prediction of MHC Class I-Restricted Immunogenic Epitopes of B-Cell Receptors Indicates T Cell-Mediated Immunosurveillance of Malignant B Cell Clones.

Anna-Maria Strothmeyer, Marcus Duehren-von Minden, MSc, Marcelo A Navarrete, MD, Kristina Heining-Mikesch, MD, Hendrik Veelken, MD

Blood (2009) 114 (22): 1949.

https://doi.org/10.1182/blood.V114.22.1949.1949

Published: 2009

Journal Articles

High-Throughput Analysis of Antigen Recognition by the B Cell Receptors of Malignant Lymphomas with High-Density Protein Microarrays.

Mareike Frick, Alla Bulashevska, PhD, Marcus Duehren-von Minden, MSc, Kristina Heining-Mikesch, MD, Dietmar Pfeifer, PhD, Hendrik Veelken, MD

Blood (2009) 114 (22): 2945.

https://doi.org/10.1182/blood.V114.22.2945.2945

Published: 2009

Journal Articles

Idiotype Vaccination of Untreated Indolent B-Cell Lymphoma: Durable Objective Remissions and Association of Superior Outcome with Cellular Immune Responses

Marcelo A. Navarrete, MD, Kristina Heining-Mikesch, MD, Cristina Bertinetti-Lapatki, PhD, Marcus Duehren-von Minden, Andrea Hafkemeyer, MD, Hendrik Veelken, MD

Blood (2008) 112 (11): 235.

https://doi.org/10.1182/blood.V112.11.235.235

Published: 2008

Journal Articles

Kinetics of Immune Responses and Tumor Burden in Patients with Indolent B Cell Lymphomas Receiving Recombinant Idiotype Vaccination as the Sole Treatment.

Cristina Bertinetti, PhD, Frank Schueler, MD, Kristina Heining-Mikesch, MD, Katja Zirlik, MD, Tina Tomann, MD, Brigitte Franke, MD, Gottfried Dolken, MD, Hendrik Veelken, MD

Blood (2006) 108 (11): 2726.

https://doi.org/10.1182/blood.V108.11.2726.2726

Published: 2006

NARROW

Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma

HLA-Dependent Immune Selection Pressure on the Idiotype Is Predominantly Driven by Somatic Hypermutation In Malignant Lymphoma but Also Modulates Vh Usage In Normal B Cells

Comparative analysis of predicted HLA binding of immunoglobulin idiotype sequences indicates T cell–mediated immunosurveillance in follicular lymphoma

Prediction of MHC Class I-Restricted Immunogenic Epitopes of B-Cell Receptors Indicates T Cell-Mediated Immunosurveillance of Malignant B Cell Clones.

High-Throughput Analysis of Antigen Recognition by the B Cell Receptors of Malignant Lymphomas with High-Density Protein Microarrays.

Idiotype Vaccination of Untreated Indolent B-Cell Lymphoma: Durable Objective Remissions and Association of Superior Outcome with Cellular Immune Responses

Kinetics of Immune Responses and Tumor Burden in Patients with Indolent B Cell Lymphomas Receiving Recombinant Idiotype Vaccination as the Sole Treatment.

Email alerts

ASH Publications

American Society of Hematology

Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma

HLA-Dependent Immune Selection Pressure on the Idiotype Is Predominantly Driven by Somatic Hypermutation In Malignant Lymphoma but Also Modulates Vh Usage In Normal B Cells

Comparative analysis of predicted HLA binding of immunoglobulin idiotype sequences indicates T cell–mediated immunosurveillance in follicular lymphoma

Prediction of MHC Class I-Restricted Immunogenic Epitopes of B-Cell Receptors Indicates T Cell-Mediated Immunosurveillance of Malignant B Cell Clones.

High-Throughput Analysis of Antigen Recognition by the B Cell Receptors of Malignant Lymphomas with High-Density Protein Microarrays.

Idiotype Vaccination of Untreated Indolent B-Cell Lymphoma: Durable Objective Remissions and Association of Superior Outcome with Cellular Immune Responses

Kinetics of Immune Responses and Tumor Burden in Patients with Indolent B Cell Lymphomas Receiving Recombinant Idiotype Vaccination as the Sole Treatment.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only